Sterling Pharma News and Resources

Sterling Pharma Solutions, a global CDMO, has entered into an agreement with biopharmaceutical company Soligenix to manufacture GMP-quality synthetic hypericin for use in the latter’s oncology drug, HyBryte. The agreement focuses on producing the compound for clinical trials, with manufacturing